NanoView Biosciences, is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biology of cellular communication and provide improved insight for how diseases are diagnosed, treated and monitored.
Location: United States, Massachusetts, Boston
Employees: 11-50
Phone: +1 781-365-8439
Total raised: $10M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Sheatrust ... | sheatrustc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.10.2018 | Series B | $10M | - |
Mentions in press and media 5
| Date | Title | Description |
| 19.08.2021 | NanoView Biosciences : Announces Key Appointments to Scientific Advisory Board | BOSTON, Aug. 19, 2021 /PRNewswire/ -- NanoView Biosciences today announced the appointment of Prof. Jan Lötvall, M.D., Ph.D., and Mark Plavsic, DVM, Ph.D., to its Scientific Advisory Board. Jan Lötvall is a Professor at the University of Go... |
| 11.10.2018 | Term Sheet — Thursday, October 11 | LAWLESS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Bird, the electric scooter startup that raised more than $400 million, operated in five cities worldwide in May. Now, in the second wee... |
| 10.10.2018 | NanoView Biosciences Completes $10M Series B Financing | NanoView Biosciences, a Boston, MA-based emerging leader in the field of exosome detection and characterization, closed a $10m Series B financing. The round was led by Northpond Ventures, with participation from existing investors Sands Cap... |
| 10.10.2018 | Daily funding roundup - October 10th, 2018 | Shujinko raised $2.8M; Accion Systems and Luminari raised $3M; Foundry College raised $6M Shujinko: Shujinko develops various cloud solutions. Shujinko leverages it's proprietary construction engine that takes hundreds of components and con... |
| 10.10.2018 | NanoView Completes $10 Million Series B Financing | BOSTON--(BUSINESS WIRE)--NanoView Biosciences, an emerging leader in the field of exosome detection and characterization, today announced the closing of a $10 million Series B financing led by Northpond Ventures. Existing investors, includi... |